YUMAB
Live / Registered — Registered — international registration renewed (as of 27 Sept 2024)
What this means for you
Registered since 11 Jul 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79191669
- Registration number
- 5238680
- Mark type
- Stylized text
- Filed
- 25 Apr 2016
- Published for opposition
- 25 Apr 2017
- Registered
- 11 Jul 2017
- Attorney of record
- Joseph V. Norvell
Goods and services
- Class 001 — Chemicals: [ Monoclonal antibodies for quantitative determination of leukocyte subsets other than for medical purposes; chemicals components being biochemicals for producing radio-labelled monoclonal antibodies for industrial or scientific purposes; proteins for detecting antibodies other than for medical purposes; ] monoclonal antibodies for industrial use; monoclonal antibody reagents, other than for medical use; antigens and antibodies being biochemicals for diagnostic use not for medical purposes; immunological antibodies, being biochemicals, other than for medical use; tagged antibodies being biochemicals for scientific use; [ monoclonal antibodies for qualitative determination of leukocyte subsets other than for medical purposes; linkage compounds being biochemicals for scientific purposes for coupling of radioactive compounds to antibodies; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; ] biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; proteins for binding antibodies other than for medical purposes; monoclonal antibodies for scientific use; [ linkage compounds being biochemicals for scientific purposes for coupling antibodies to radio nuclides; monoclonal antibodies for research into haematopoietic systems other than for medical purposes; ] reagents for use in development of monoclonal antibodies other than for medical or veterinary purposes; [ components for producing radio-labelled antibody fragments for industrial or scientific purposes being biochemicals; ] tagged antibodies being biochemicals for laboratory use; reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) other than for medical or veterinary purposes comprised primarily of biochemicals
- Class 005 — Pharmaceuticals: Antibodies, antibody fragments and antigens in the nature of pharmaceuticals for the treatment of cancer, haematopoietic diseases, autoimmune diseases, neurodegenerative diseases, metabolic diseases, eye diseases, infections, diseases of heart and circulation, bone diseases, transplantation, sepsis, intoxications, and adverse drug reactions
- Class 042 — Scientific and technological services: Scientific research; technological services being antibody engineering and design; industrial analysis and research services in the nature of laboratory research and new product design services relating to the production of monoclonal antibodies
Owner
- YUMAB GmbH, Braunschweig, DE
- YUMAB GmbH, DE
- YUMAB GmbH, DE
Prosecution history
- 08 Feb 2025 — TOTAL INVALIDATION PROCESSED BY THE IB
- 15 Jan 2025 — GENERIC MADRID TRANSACTION SENT TO IB
- 15 Jan 2025 — GENERIC MADRID TRANSACTION CREATED
- 04 Dec 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 27 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 27 Sept 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 17 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 03 Apr 2024 — POST REGISTRATION ACTION MAILED - SEC. 71 & 15
- 25 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jul 2023 — TEAS SECTION 71 & 15 RECEIVED
- 18 Feb 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 15 Aug 2019 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 10 Nov 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Oct 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Oct 2017 — FINAL DISPOSITION PROCESSED